OverviewSuggest Edit

IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on the Company's technological expertise and scientific know how.
HQÉvry, FR

Latest Updates

Employees (est.) (Jul 2021)53(+24%)
Share Price (Jul 2021)€1.6(+8%)
Cybersecurity ratingBMore

Key People/Management at IntegraGen

Bernard Courtieu

Bernard Courtieu

Chairman and Chief Executive Officer
Jean Stephenne

Jean Stephenne

Laurence Riot Lamotte

Laurence Riot Lamotte

Chief Financial Officer
Emmanuel Martin

Emmanuel Martin

Sales and Marketing Director
Bérengère Génin

Bérengère Génin

Director of Bioinformatics
Catherine David

Catherine David

Quality Director
Show more

IntegraGen Office Locations

IntegraGen has offices in Évry and Cambridge
Évry, FR (HQ)
5 Rue Henri Auguste Desbruères
Cambridge, MA, US
1 Mifflin Pl #400
Show all (2)

IntegraGen Financials and Metrics

IntegraGen Revenue

Market capitalization (22-Jul-2021)


Closing stock price (22-Jul-2021)

IntegraGen's current market capitalization is €10.9 m.
Show all financial metrics

IntegraGen Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

IntegraGen Online and Social Media Presence

Embed Graph

IntegraGen Blogs

3’RNA-seq for accurate gene expression analysis of challenging tumor samples

A Powerful Workflow to Access Cancer Gene Expression Signatures In additional to DNA sequencing, RNA sequencing can provide researchers and clinicians with additional insights into tumor tissues. The technology offers the opportunity to explore the gene expression profiles and the states of tumor c…

IntegraGen reports sales of 4.8 M€ for the first half of 2021, a 2% increase versus 2020, and a cash position of 4.3 M€

Slight revenue growth despite the impact of the pandemic during the first half of the year. Strong increase in order intake sets the stage for an anticipated dynamic growth during the second half of the 2021. EVRY, FRANCE, FRIDAY 16 JULY 2021, 7.30AM – IntegraGen (FR0010908723 – ALINT (…) (…) (+) …

IntegraGen supports the Antoine Lacassagne Cancer Center in Nice to carry out a large-scale research project in colorectal cancer patients

Founded in 1961, the Antoine Lacassagne Center is one of the 18 French Cancer Centers of the Unicancer network. It fulfills missions of care, research and teaching in oncology. The Antoine Lacassagne Center treats all types of cancer and receives more than 6,400 patients (…) (+) The post IntegraGen …

New Look. New Portfolio. New Opportunities.

Following its acquisition by OncoDNA, IntegraGen has been given a brand new look and is ready to take on new projects in the fields of cancer and genetic diseases. Since the successful takeover in November 2020, IntegraGen has been working hand in hand with OncoDNA (…) (+) The post New Look. New Po…

New perspectives for the diagnosis and treatment of cisplatin-resistant pediatric liver cancers

Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer IntegraGen is delighted to share this new publication on tumor plasticity and cisplatin resistance in pediatric liver cancers. Sequencing services (WES, RNA-seq, snRNA-seq, RRB…

IntegraGen reports 2020 annual results: 10% growth in revenue from current operations and achievement of breakeven operating profits

Bernard Courtieu, CEO of IntegraGen said: “2020 was an exceptional year for IntegraGen in several ways. Commercial activities achieved double-digit growth, results were close to breakeven for the second consecutive year, and the company’s cash position was strengthened, despite the considerable impa…
Show more

IntegraGen Frequently Asked Questions

  • When was IntegraGen founded?

    IntegraGen was founded in 2000.

  • Who are IntegraGen key executives?

    IntegraGen's key executives are Bernard Courtieu, Jean Stephenne and Laurence Riot Lamotte.

  • How many employees does IntegraGen have?

    IntegraGen has 53 employees.

  • Who are IntegraGen competitors?

    Competitors of IntegraGen include Medicalsystem Biotechnology, One Lambda and Diater.

  • Where is IntegraGen headquarters?

    IntegraGen headquarters is located at 5 Rue Henri Auguste Desbruères, Évry.

  • Where are IntegraGen offices?

    IntegraGen has offices in Évry and Cambridge.

  • How many offices does IntegraGen have?

    IntegraGen has 2 offices.